CompletedNot Applicable

Comparison of VentiBroncTM Anchor With Conventional Double-lumen Endobronchial Tube in Patients With High Risk of Malposition

South Korea154 participantsStarted 2023-10-26

Plain-language summary

The investigators intend to compare the group using triple-cuffed endobronchial tube (VentiBroncTM Anchor) with the group using the conventional double-lumen endotracheal tube (Shiley®) in patients at high risk of malposition of the double-lumen endotracheal tube. The aim of this study is to determine if the use of VentiBroncTM Anchor increases the success rate of optimal double-lumen intubation to left main bronchus.

Who can participate

Age range20 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients requiring left double-lumen endotracheal tube intubation for thoracic surgery. ASA physical status classification 2-4. Female patients aged 20-85 with a height of 160cm or less and a body mass index (BMI) of 25.0 kg/m2 or higher. Patients requiring VentiBroncTM Anchor 33Fr or Shiley® 32Fr intubation due to a left mainstem bronchus diameter of 11mm or less on chest CT. Exclusion Criteria: Intraluminal lesions in the left or right mainstem bronchi. History of airway surgery. Emergency surgery.

What they're measuring

Success rate of endobronchial intubation

Timeframe: Immediately after double-lumen tube intubation, with flexible fiberoptic bronchoscope

Trial details

NCT IDNCT06061055

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-26

View on ClinicalTrials.gov More Endotracheal Intubation trials